Recent studies have also shown the preventive efficacy of Nrf2 activators in pancreatic tumorigenesis and the suppressive effects of Nrf2 inhibitors on PC growth and metastasis [16–19]. Here, NFE2L2 is linked to pachyonychia congenita.